Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice – Results of the Non-Interventional DETECT Study

Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice – Results of the Non-Interventional DETECT Study

Tanja Plate,1 Felix W Friedrich,1 Jutta Beier2 1AstraZeneca GmbH, Wedel, Germany; 2Insaf - Respiratory Research Institute GmbH, Wiesbaden, GermanyCorrespondence: Felix W FriedrichAstraZeneca GmbH, Tinsdaler Weg 183, Wedel D-22880, GermanyTel +49 162 1398835Fax +49 4103 70873707Email felix.friedrich@...

Full description

Bibliographic Details
Main Authors: Plate T, Friedrich FW, Beier J
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:International Journal of COPD
Subjects:
chronic obstructive pulmonary disease
combination therapy
bronchodilators
chronic bronchitis
long acting muscarinic antagonists
long-acting β2-agonists
Online Access:https://www.dovepress.com/effectiveness-and-tolerability-of-labalama-fixed-dose-combinations-acl-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/effectiveness-and-tolerability-of-labalama-fixed-dose-combinations-acl-peer-reviewed-article-COPD

Similar Items